Zobrazeno 1 - 10
of 229
pro vyhledávání: '"Jolanta M. Siller‐Matula"'
Autor:
Zofia Wicik, Ceren Eyileten, Anna Nowak, Disha Keshwani, Sérgio N. Simões, David C. Martins, Krzysztof Klos, Wojciech Wlodarczyk, Alice Assinger, Dariusz Soldacki, Andrzej Chcialowski, Jolanta M. Siller-Matula, Marek Postula
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-13 (2024)
Abstract Angiotensin converting enzyme 2 (ACE2) serves as the primary receptor for the SARS-CoV-2 virus and has implications for the functioning of the cardiovascular system. Based on our previously published bioinformatic analysis, in this study we
Externí odkaz:
https://doaj.org/article/2c3e18bac9a04d93854537d63e5fb8e0
Autor:
Vikash Jaiswal, Dattatreya Mukherjee, Song Peng Ang, Tejasvi Kainth, Sidra Naz, Abhigan Babu Shrestha, Vibhor Agrawal, Saloni Mitra, Jia Ee Chia, Bernd Jilma, Mamas A. Mamas, Catherine Gebhard, Marek Postula, Jolanta M. Siller-Matula
Publikováno v:
International Journal of Cardiology: Heart & Vasculature, Vol 49, Iss , Pp 101280- (2023)
Background: Myocarditis secondary to Coronavirus Disease 2019 (COVID-19) vaccination has been reported in the literature. Objective: This study aimed to characterize the reported cases of myocarditis after COVID-19 vaccination based on age, gender, d
Externí odkaz:
https://doaj.org/article/165c5673102f4441a112fdea5dc7cbe2
Autor:
Ceren Eyileten, Zofia Wicik, Sérgio N. Simões, David C. Martins-Jr, Krzysztof Klos, Wojciech Wlodarczyk, Alice Assinger, Dariusz Soldacki, Andrzej Chcialowski, Jolanta M. Siller-Matula, Marek Postula
Publikováno v:
RNA Biology, Vol 19, Iss 1, Pp 963-979 (2022)
SARS-CoV-2 tropism for the ACE2 receptor, along with the multifaceted inflammatory reaction, is likely to drive the generalized hypercoagulable and thrombotic state seen in patients with COVID-19. Using the original bioinformatic workflow and network
Externí odkaz:
https://doaj.org/article/14e826d590424a98ae2aa0fd5ebe3749
Autor:
Zofia Wicik, Pamela Czajka, Ceren Eyileten, Alex Fitas, Marta Wolska, Daniel Jakubik, Dirk von Lewinski, Harald Sourij, Jolanta M. Siller-Matula, Marek Postula
Publikováno v:
Platelets, Vol 33, Iss 7, Pp 1052-1064 (2022)
MicroRNAs (miRNAs) are small, non-coding RNAs, able to regulate cellular functions by induction of mRNA degradation and post-transcriptional repression of gene expression. Platelets are the major source of circulating miRNAs, with significant regulat
Externí odkaz:
https://doaj.org/article/f18f0a52a10c4451b4bcc0ed3a6159a7
Autor:
Ceren Eyileten, Zofia Wicik, Disha Keshwani, Faisal Aziz, Felix Aberer, Peter N. Pferschy, Norbert J. Tripolt, Caren Sourij, Barbara Prietl, Florian Prüller, Dirk von Lewinski, Salvatore De Rosa, Jolanta M. Siller-Matula, Marek Postula, Harald Sourij
Publikováno v:
Cardiovascular Diabetology, Vol 21, Iss 1, Pp 1-12 (2022)
Abstract Background In patients with type 2 diabetes mellitus (T2DM) an association between severe hypoglycaemic episodes and the risk of cardiovascular (CV) morbidity and mortality has been previously established. Methods We aimed to investigate the
Externí odkaz:
https://doaj.org/article/8c4a4795816e4211b76da3ec73f6544e
Autor:
Georg Gelbenegger, Juergen Grafeneder, Gloria M. Gager, Jolanta M. Siller-Matula, Michael Schwameis, Bernd Jilma, Christian Schoergenhofer
Publikováno v:
Thrombosis Journal, Vol 20, Iss 1, Pp 1-11 (2022)
Abstract Background High on-treatment platelet reactivity (HTPR) remains a major problem in the acute management of ST-elevation myocardial infarction (STEMI), leading to higher rates of stent thrombosis and mortality. We aimed to investigate a novel
Externí odkaz:
https://doaj.org/article/fa89bc04d7374f58ab4cab59347007d1
Autor:
Zofia Wicik, Anna Nowak, Joanna Jarosz-Popek, Marta Wolska, Ceren Eyileten, Jolanta M. Siller-Matula, Dirk von Lewinski, Harald Sourij, Krzysztof J. Filipiak, Marek Postuła
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Background: Sodium–glucose cotransporter 2 (SGLT2), also known as solute carrier family 5 member 2 (SLC5A2), is a promising target for a new class of drugs primarily established as kidney-targeting, effective glucose-lowering agents used in diabete
Externí odkaz:
https://doaj.org/article/782e0e5f5ed0436c94e5647ef11ab02d
Autor:
Benedikt S. Biesinger, Aleksandra Gasecka, Thomas Perkmann, Johann Wojta, Maciej Lesiak, Marek Grygier, Ceren Eyileten, Marek Postuła, Krzysztof J. Filipiak, Aurel Toma, Christian Hengstenberg, Jolanta M. Siller-Matula
Publikováno v:
Platelets, Vol 32, Iss 4, Pp 498-506 (2021)
Inflammation leads to atherosclerosis and acute coronary syndromes (ACS). We performed a prospective, observational study to assess association between the concentrations of inflammatory markers (high sensitivity C-reactive protein, hsCRP; high sensi
Externí odkaz:
https://doaj.org/article/563a4eff470541b8970ad18cd637bdb3
Autor:
Daniel Jakubik, Alex Fitas, Ceren Eyileten, Joanna Jarosz-Popek, Anna Nowak, Pamela Czajka, Zofia Wicik, Harald Sourij, Jolanta M. Siller-Matula, Salvatore De Rosa, Marek Postula
Publikováno v:
Cardiovascular Diabetology, Vol 20, Iss 1, Pp 1-29 (2021)
Abstract The epidemic of diabetes mellitus (DM) necessitates the development of novel therapeutic and preventative strategies to attenuate complications of this debilitating disease. Diabetic cardiomyopathy (DCM) is a frequent disorder affecting indi
Externí odkaz:
https://doaj.org/article/fa01639cb5ba486c823fac723ed15149
Autor:
Marek Koziński, Joanna Rejszel-Baranowska, Elżbieta Młodawska, Jolanta M. Siller-Matula, Anna Tomaszuk-Kazberuk
Publikováno v:
Advances in Interventional Cardiology, Vol 16, Iss 2, Pp 127-137 (2020)
Selection of the optimal peri- and postprocedural antithrombotic regimen in patients with atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI) is a common clinical problem which may pose a challenge to medical practitioners. T
Externí odkaz:
https://doaj.org/article/db48a90338b94bd7b02c1566ce8d177a